Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us dr. S.F. Oosting

Publications

Comparison of White Light With Narrow Band Imaging Using Flexible Laryngoscopy for the Detection of Local Recurrences After (Chemo)Radiation for Pharyngeal or Laryngeal Cancer: A Randomised Controlled Trial

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Impact of CMV Infection and Cancer Treatment on Vaccine Efficacy in Oncology Patients

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum

Prospective Randomised Phase-II Trial of Ipilimumab/Nivolumab versus Standard of Care in non-clear cell Renal Cell Cancer - Results of the SUNNIFORECAST Trial

Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment

Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands: A nationwide evaluation study

Press/media

ESMO Releases Version 2.0 of the Magnitude of Clinical Benefit Scale

Checklist Aims to Boost Quality of Life in Clinical Trials

Novel checklist for Quality of Life to bring ESMO-MCBS and clinical trials to the next level

Podcast over hoofd-hals-tumoren

Vaccino Covid: nei pazienti in chemioterapia buona risposta anticorpale

COVID-19 vaccination safe, effective during treatment for solid tumors